Trevi Therapeutics price target raised to $20 from $12 at Oppenheimer
Oppenheimer raised the firm’s price target on Trevi Therapeutics (TRVI) to $20 from $12 and keeps an Outperform rating on the shares. The firm ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Trevi Therapeutics (TRVI)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioNTech SE (BNTX – Research Report) and ...
U.S. News & World Report1d
Trevi Fountain (Fontana di Trevi)
A must-see on many travelers' itineraries, the Trevi Fountain is situated amongst a high concentration of hotels, shopping and nightlife in the Trevi district. Finished in the mid-1700s ...